Mode
Text Size
Log in / Sign up
N/A N=56 Randomized Prevention

Effect of Chewing Gum in Hemodialysis Patients

Chewing Gum · Hemodialysis

Enrolled (actual)
56
Serious AEs
Results posted
May 2020
Primary outcome: Primary: Change From Baseline Intradialytic Weight Gain — 2.53; 2.44 kg

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Chewing Gum (Dietary_supplement)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Istanbul Demiroglu Bilim University
Primary completion
Jan 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Change From Baseline Intradialytic Weight Gain
2.53; 2.44
PRIMARY
Change From Baseline Feeling of Thirst at Three Months
5.04; 1.72
PRIMARY
Change From Baseline Dry Mouth at Three Months
5.04; 1.72
PRIMARY
Change From Baseline Dry Mouth at Three Months
5.04; 1.72
PRIMARY
Change From Baseline Intradialytic Symptoms at Three Months
19.13; 19.18
SECONDARY
Change From Baseline Anxiety at Three Months
8.18; 8.40
SECONDARY
Change From Baseline Fluid Control at Three Months
53.95; 58.04
SECONDARY
Change From Baseline Depression at Three Months
8.63; 8.13

Summary

The aim of this prospective randomized controlled study was to investigate the effects of chewing gum on interdialytic weight gain, thirst, dry mouth and intradialytic symptoms in hemodialysis patients.

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • On maintenance hemodialysis three times per week for four hours per session
  • Receiving hemodialysis therapy for a least six moths at the time of the study
  • Able to communicate in Turkish
  • Willing to participate to the study

Exclusion Criteria

  • 18 years of age younger
  • Absence of psychiatric disorders that cause cognitive dysfunction, such as Alzheimer's disease or chronic psychosis.
  • The patient who took chemotherapy and radiotherapy
  • Have salivary gland infection and dementia
  • Oral and / or dental diseases to prevent chewing gum
  • Unwilling to to participate to the study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04142216). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search